These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 31576791)

  • 1. Cariprazine efficacy in bipolar I depression with and without concurrent manic symptoms: post hoc analysis of 3 randomized, placebo-controlled studies.
    McIntyre RS; Suppes T; Earley W; Patel M; Stahl SM
    CNS Spectr; 2020 Aug; 25(4):502-510. PubMed ID: 31576791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full-spectrum efficacy of cariprazine across manic and depressive symptoms of bipolar I disorder in patients experiencing mood episodes: Post hoc analysis of pooled randomized controlled trial data.
    Vieta E; McIntyre RS; Yu J; Aronin LC; Kramer K; Nguyen HB
    J Affect Disord; 2024 Dec; 366():136-145. PubMed ID: 39187200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials.
    McIntyre RS; Masand PS; Earley W; Patel M
    J Affect Disord; 2019 Oct; 257():600-606. PubMed ID: 31344528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of low- and high-dose cariprazine in acute and mixed mania associated with bipolar I disorder: a double-blind, placebo-controlled study.
    Calabrese JR; Keck PE; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Clin Psychiatry; 2015 Mar; 76(3):284-92. PubMed ID: 25562205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications.
    Yatham LN; Vieta E; McIntyre RS; Jain R; Patel M; Earley W
    Prim Care Companion CNS Disord; 2020 Sep; 22(5):. PubMed ID: 32942346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early improvement with cariprazine as a predictor of antidepressant, anxiolytic, and antimanic response in bipolar I mania and depression: A pooled post hoc analysis of randomized cariprazine trials.
    Tohen M; Yu J; Kramer K; Nguyen HB
    J Affect Disord; 2024 Oct; 362():194-200. PubMed ID: 38942209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cariprazine Treatment of Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Phase 3 Study.
    Earley W; Burgess MV; Rekeda L; Dickinson R; Szatmári B; Németh G; McIntyre RS; Sachs GS; Yatham LN
    Am J Psychiatry; 2019 Jun; 176(6):439-448. PubMed ID: 30845817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinically relevant response and remission outcomes in cariprazine-treated patients with bipolar I disorder.
    Earley W; Durgam S; Lu K; Ruth A; Németh G; Laszlovszky I; Yatham LN
    J Affect Disord; 2018 Jan; 226():239-244. PubMed ID: 29017067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and tolerability of cariprazine in acute mania associated with bipolar I disorder: a phase II trial.
    Durgam S; Starace A; Li D; Migliore R; Ruth A; Németh G; Laszlovszky I
    Bipolar Disord; 2015 Feb; 17(1):63-75. PubMed ID: 25056368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder.
    Citrome L; Li C; Yu J; Kramer K; Nguyen HB
    J Affect Disord; 2024 Aug; 358():353-360. PubMed ID: 38657773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
    Durgam S; Earley W; Guo H; Li D; Németh G; Laszlovszky I; Fava M; Montgomery SA
    J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of cariprazine in bipolar I depression: A double-blind, placebo-controlled phase 3 study.
    Earley WR; Burgess MV; Khan B; Rekeda L; Suppes T; Tohen M; Calabrese JR
    Bipolar Disord; 2020 Jun; 22(4):372-384. PubMed ID: 31628698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cariprazine across the symptoms of mania in bipolar I disorder: Analyses of pooled data from phase II/III trials.
    Vieta E; Durgam S; Lu K; Ruth A; Debelle M; Zukin S
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):1882-91. PubMed ID: 26419293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An 8-Week Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Cariprazine in Patients With Bipolar I Depression.
    Durgam S; Earley W; Lipschitz A; Guo H; Laszlovszky I; Németh G; Vieta E; Calabrese JR; Yatham LN
    Am J Psychiatry; 2016 Mar; 173(3):271-81. PubMed ID: 26541814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cariprazine in the treatment of acute mania in bipolar I disorder: a double-blind, placebo-controlled, phase III trial.
    Sachs GS; Greenberg WM; Starace A; Lu K; Ruth A; Laszlovszky I; Németh G; Durgam S
    J Affect Disord; 2015 Mar; 174():296-302. PubMed ID: 25532076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of cariprazine in bipolar I depression across patient characteristics: a post hoc analysis of pooled randomized, placebo-controlled studies.
    Patel M; Jain R; Tohen M; Maletic V; Earley WR; Yatham LN
    Int Clin Psychopharmacol; 2021 Mar; 36(2):76-83. PubMed ID: 33230026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies.
    Earley W; Durgam S; Lu K; Debelle M; Laszlovszky I; Vieta E; Yatham LN
    J Affect Disord; 2017 Jun; 215():205-212. PubMed ID: 28343051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of cariprazine on cognition: a post hoc analysis from phase II/III clinical trials in bipolar mania, bipolar depression, and schizophrenia.
    McIntyre RS; Daniel DG; Vieta E; Laszlovszky I; Goetghebeur PJ; Earley WR; Patel MD
    CNS Spectr; 2023 Jun; 28(3):319-330. PubMed ID: 35193729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.